In pancreatic cancer, YBX1 binds to the GSK3B promoter and promotes the growth of pancreatic ductal adenocarcinoma through the GSK3B/Cyclin D1/Cyclin E1 pathway (12). This evidence concerns the gene GSK3B and pancreatic ductal adenocarcinoma.